{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:24:03Z","timestamp":1778279043438,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00417-018-4169-4","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T18:27:17Z","timestamp":1540924037000},"page":"187-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inflammatory mediators in the vitreal reflux of patients with diabetic macular edema"],"prefix":"10.1007","volume":"257","author":[{"given":"Andrea","family":"Cacciamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziana","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Scarinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariacristina","family":"Parravano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Dinice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Di Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-6071","authenticated-orcid":false,"given":"Alessandra","family":"Micera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"4169_CR1","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.2337\/dc10-1580","volume":"33","author":"P Romero-Aroca","year":"2010","unstructured":"Romero-Aroca P (2010) Targeting the pathophysiology of diabetic macular edema. Diabetes Care 33:2484\u20132485. \n                    https:\/\/doi.org\/10.2337\/dc10-1580","journal-title":"Diabetes Care"},{"key":"4169_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.pop.2015.05.005","volume":"42","author":"AM Hendrick","year":"2015","unstructured":"Hendrick AM, Gibson MV, Kulshreshtha A (2015) Diabetic retinopathy. Prim Care 42:451\u2013464. \n                    https:\/\/doi.org\/10.1016\/j.pop.2015.05.005","journal-title":"Prim Care"},{"key":"4169_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10654-017-0338-8","volume":"33","author":"C Dow","year":"2018","unstructured":"Dow C, Mancini F, Rajaobelina K et al (2018) Diet and risk of diabetic retinopathy: a systematic review. Eur J Epidemiol 33:141\u2013156. \n                    https:\/\/doi.org\/10.1007\/s10654-017-0338-8","journal-title":"Eur J Epidemiol"},{"key":"4169_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","volume":"63","author":"A Daruich","year":"2018","unstructured":"Daruich A, Matet A, Moulin A et al (2018) Mechanisms of macular edema: beyond the surface. Prog Retin Eye Res 63:20\u201368. \n                    https:\/\/doi.org\/10.1016\/j.preteyeres.2017.10.006","journal-title":"Prog Retin Eye Res"},{"key":"4169_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/ceo.12757","volume":"44","author":"H Mehta","year":"2016","unstructured":"Mehta H, Gillies MC, Fraser-Bell S (2016) Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review. Clin Exp Ophthalmol 44:335\u2013339. \n                    https:\/\/doi.org\/10.1111\/ceo.12757","journal-title":"Clin Exp Ophthalmol"},{"key":"4169_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/CIA.S36811","volume":"8","author":"AH Fong","year":"2013","unstructured":"Fong AH, Lai TY (2013) Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema. Clin Interv Aging 8:467\u2013483. \n                    https:\/\/doi.org\/10.2147\/CIA.S36811","journal-title":"Clin Interv Aging"},{"key":"4169_CR7","doi-asserted-by":"publisher","first-page":"920713","DOI":"10.1155\/2013\/920713","volume":"2013","author":"T Murakami","year":"2013","unstructured":"Murakami T, Yoshimura N (2013) Structural changes in individual retinal layers in diabetic macular edema. J Diabetes Res 2013:920713. \n                    https:\/\/doi.org\/10.1155\/2013\/920713","journal-title":"J Diabetes Res"},{"key":"4169_CR8","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.3928\/15428877-20110627-04","volume":"42 Suppl","author":"AM Schimel","year":"2011","unstructured":"Schimel AM, Fisher YL, Flynn HW Jr (2011) Optical coherence tomography in the diagnosis and management of diabetic macular edema: time-domain versus spectral-domain. Ophthalmic Surg Lasers Imaging 42 Suppl:S41\u2013S55. \n                    https:\/\/doi.org\/10.3928\/15428877-20110627-04","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"4169_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.22608\/APO.2017350","volume":"6","author":"B Bahrami","year":"2017","unstructured":"Bahrami B, Hong T, Gilles MC, Chang A (2017) Anti-VEGF therapy for diabetic eye diseases. Asia Pac J Ophthalmol (Phila) 6:535\u2013545. \n                    https:\/\/doi.org\/10.22608\/APO.2017350","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"4169_CR10","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3928\/23258160-20170829-10","volume":"48","author":"T Banaee","year":"2017","unstructured":"Banaee T, Ashraf M, Conti FF, Singh RP (2017) Switching anti-VEGF drugs in the treatment of diabetic macular edema. Ophthalmic Surg Lasers Imaging Retina 48:748\u2013754. \n                    https:\/\/doi.org\/10.3928\/23258160-20170829-10","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"4169_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000460275","volume":"60","author":"S Rizzo","year":"2017","unstructured":"Rizzo S, Bacherini D (2017) Enzymatic vitreolysis for vitreomacular traction in diabetic retinopathy. Dev Ophthalmol 60:160\u2013164. \n                    https:\/\/doi.org\/10.1159\/000460275","journal-title":"Dev Ophthalmol"},{"key":"4169_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000459691","volume":"60","author":"R Lattanzio","year":"2017","unstructured":"Lattanzio R, Cicinelli MV, Bandello F (2017) Intravitreal steroids in diabetic macular edema. Dev Ophthalmol 60:78\u201390. \n                    https:\/\/doi.org\/10.1159\/000459691","journal-title":"Dev Ophthalmol"},{"key":"4169_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3109\/02713683.2015.1080282","volume":"41","author":"A Cacciamani","year":"2016","unstructured":"Cacciamani A, Parravano M, Scarinci F, Esposito G, Varano M, Micera A (2016) A simple spontaneous vitreal reflux collecting procedure during intravitreal injection: set-up and validation studies. Curr Eye Res 41:971\u2013976. \n                    https:\/\/doi.org\/10.3109\/02713683.2015.1080282","journal-title":"Curr Eye Res"},{"key":"4169_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/aos.12812","volume":"94","author":"S Vujosevic","year":"2016","unstructured":"Vujosevic S, Micera A, Bini S, Berton M, Esposito G, Midena E (2016) Proteome analysis of retinal glia cells-related inflammatory cytokines in the aqueous humour of diabetic patients. Acta Ophthalmol 94:56\u201364. \n                    https:\/\/doi.org\/10.1111\/aos.12812","journal-title":"Acta Ophthalmol"},{"key":"4169_CR15","doi-asserted-by":"publisher","first-page":"BIO68","DOI":"10.1167\/iovs.17-21769","volume":"58","author":"S Vujosevic","year":"2017","unstructured":"Vujosevic S, Sim\u00f3 R (2017) Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach. Invest Ophthalmol Vis Sci 58:BIO68\u2013BIO75. \n                    https:\/\/doi.org\/10.1167\/iovs.17-21769","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4169_CR16","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1167\/iovs.17-21973","volume":"58","author":"JD Boss","year":"2017","unstructured":"Boss JD, Singh PK, Pandya HK et al (2017) Assessment of neurotrophins and inflammatory mediators in vitreous of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 58:5594\u20135603. \n                    https:\/\/doi.org\/10.1167\/iovs.17-21973","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4169_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.exer.2016.01.001","volume":"146","author":"M Nobl","year":"2016","unstructured":"Nobl M, Reich M, Dacheva I et al (2016) Proteomics of vitreous in neovascular age-related macular degeneration. Exp Eye Res 146:107\u2013117. \n                    https:\/\/doi.org\/10.1016\/j.exer.2016.01.001","journal-title":"Exp Eye Res"},{"key":"4169_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89\u201395. \n                    https:\/\/doi.org\/10.1067\/mcp.2001.113989","journal-title":"Clin Pharmacol Ther"},{"key":"4169_CR19","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480\u20131487. \n                    https:\/\/doi.org\/10.1056\/NEJM199412013312203","journal-title":"N Engl J Med"},{"key":"4169_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaophthalmol.2017.6565","volume":"136","author":"NM Bressler","year":"2018","unstructured":"Bressler NM, Beaulieu WT, Glassman AR et al (2018) Persistent macular thickening following intravitreous aflibercept, bevacizumab, or ranibizumab for central-involved diabetic macular edema with vision impairment: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol 136:257\u2013269. \n                    https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.6565","journal-title":"JAMA Ophthalmol"},{"key":"4169_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","volume":"117","author":"MJ Elman","year":"2010","unstructured":"Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW et al (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophtalmology 117:1064\u20131077. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2010.02.031","journal-title":"Ophtalmology"},{"key":"4169_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12325-016-0285-x","volume":"33","author":"A Micera","year":"2016","unstructured":"Micera A, Quaranta L, Esposito G et al (2016) Differential protein expression profiles in glaucomatous trabecular meshwork: an evaluation study on a small primary open angle glaucoma population. Adv Ther 33:252\u2013267. \n                    https:\/\/doi.org\/10.1007\/s12325-016-0285-x","journal-title":"Adv Ther"},{"key":"4169_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","volume":"167","author":"R Horst Ter","year":"2016","unstructured":"Ter Horst R, Jaeger M, Smeekens SP et al (2016) Host and environmental factors influencing individual human cytokine responses. Cell 167:1111\u20131124.e13. \n                    https:\/\/doi.org\/10.1016\/j.cell.2016.10.018","journal-title":"Cell"},{"key":"4169_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/CIA.S93820","volume":"11","author":"K Michalska-Ma\u0142ecka","year":"2016","unstructured":"Michalska-Ma\u0142ecka K, Kabiesz A, Kimsa MW et al (2016) Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration. Clin Interv Aging 11:357\u2013365. \n                    https:\/\/doi.org\/10.2147\/CIA.S93820","journal-title":"Clin Interv Aging"},{"key":"4169_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/0301-4738.126186","volume":"62","author":"SS Dabir","year":"2014","unstructured":"Dabir SS, Das D, Nallathambi J, Mangalesh S, Yadav NK, Schouten JS (2014) Differential systemic gene expression profile in patients with diabetic macular edema: responders versus nonresponders to standard treatment. Indian J Ophthalmol 62:66\u201373. \n                    https:\/\/doi.org\/10.4103\/0301-4738.126186","journal-title":"Indian J Ophthalmol"},{"key":"4169_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/ICU.0000000000000424","volume":"28","author":"S Cai","year":"2017","unstructured":"Cai S, Bressler NM (2017) Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T. Curr Opin Ophthalmol 28:636\u2013643. \n                    https:\/\/doi.org\/10.1097\/ICU.0000000000000424","journal-title":"Curr Opin Ophthalmol"},{"key":"4169_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11892-013-0382-z","volume":"13","author":"LA Owen","year":"2013","unstructured":"Owen LA, Hartnett ME (2013) Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema. Curr Diab Rep 13:476\u2013480. \n                    https:\/\/doi.org\/10.1007\/s11892-013-0382-z","journal-title":"Curr Diab Rep"},{"key":"4169_CR28","doi-asserted-by":"publisher","first-page":"478509","DOI":"10.1155\/2015\/478509","volume":"2015","author":"L Krizova","year":"2015","unstructured":"Krizova L, Kalousova M, Kubena AA et al (2015) Correlation of vitreous vascular endothelial growth factor and uric acid concentration using optical coherence tomography in diabetic macular edema. J Ophthalmol 2015:478509. \n                    https:\/\/doi.org\/10.1155\/2015\/478509","journal-title":"J Ophthalmol"},{"key":"4169_CR29","doi-asserted-by":"publisher","first-page":"95103","DOI":"10.1155\/2007\/95103","volume":"2007","author":"TS Kern","year":"2007","unstructured":"Kern TS (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007:95103. \n                    https:\/\/doi.org\/10.1155\/2007\/95103","journal-title":"Exp Diabetes Res"},{"key":"4169_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/1756-0500-7-617","volume":"7","author":"S Golan","year":"2014","unstructured":"Golan S, Entin-Meer M, Semo Y et al (2014) Gene profiling of human VEGF signaling pathways in human endothelial and retinal pigment epithelial cells after anti VEGF treatment. BMC Res Notes 7:617. \n                    https:\/\/doi.org\/10.1186\/1756-0500-7-617","journal-title":"BMC Res Notes"},{"key":"4169_CR31","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1167\/iovs.09-3910","volume":"51","author":"FM Mo","year":"2010","unstructured":"Mo FM, Proia AD, Johnson WH, Cyr D, Lashkari K (2010) Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci 51:4226\u20134236. \n                    https:\/\/doi.org\/10.1167\/iovs.09-3910","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4169_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000102936","volume":"39","author":"S Kase","year":"2007","unstructured":"Kase S, Yokoi M, Saito W et al (2007) Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic Res 39:143\u2013147. \n                    https:\/\/doi.org\/10.1159\/000102936","journal-title":"Ophthalmic Res"},{"key":"4169_CR33","first-page":"1209","volume":"20","author":"AM Abu El-Asrar","year":"2014","unstructured":"Abu El-Asrar AM, Nawaz MI, De Hertogh G et al (2014) S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis. Mol Vis 20:1209\u20131224","journal-title":"Mol Vis"},{"key":"4169_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bone.2015.05.047","volume":"81","author":"D Ramchandani","year":"2015","unstructured":"Ramchandani D, Weber GF (2015) Interactions between osteopontin and vascular endothelial growth factor: implications for skeletal disorders. Bone 81:7\u201315. \n                    https:\/\/doi.org\/10.1016\/j.bone.2015.05.047","journal-title":"Bone"},{"key":"4169_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000475670","volume":"58","author":"QK Lu","year":"2017","unstructured":"Lu QK, Zhang JT, Zhao N, Wang HY, Tong QH, Wang SL (2017) Association of IL-6 gene (-174 and -572 G\/C) polymorphisms with proliferative diabetic retinopathy of type 2 diabetes in a Chinese population. Ophthalmic Res 58:162\u2013167. \n                    https:\/\/doi.org\/10.1159\/000475670","journal-title":"Ophthalmic Res"},{"key":"4169_CR36","first-page":"1005","volume":"22","author":"H Chen","year":"2016","unstructured":"Chen H, Zhang X, Liao N, Wen F (2016) Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy. Mol Vis 22:1005\u20131014","journal-title":"Mol Vis"},{"key":"4169_CR37","doi-asserted-by":"publisher","first-page":"16186","DOI":"10.1074\/jbc.M116.718551","volume":"291","author":"J Wolf","year":"2016","unstructured":"Wolf J, Waetzig GH, Chalaris A et al (2016) Different soluble forms of the Interleukin-6 family signal transducer gp130 fine-tune the blockade of Interleukin-6 trans-signaling. J Biol Chem 291:16186\u201316196. \n                    https:\/\/doi.org\/10.1074\/jbc.M116.718551","journal-title":"J Biol Chem"},{"key":"4169_CR38","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/hmg\/ddg132","volume":"12","author":"OP Kristiansen","year":"2003","unstructured":"Kristiansen OP, Nols\u00f8e RL, Larsen L et al (2003) Association of a functional 17beta-estradiol sensitive IL6-174G\/C promoter polymorphism with early-onset type 1 diabetes in females. Hum Mol Genet 12:1101\u20131110","journal-title":"Hum Mol Genet"},{"key":"4169_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.eye.6702584","volume":"22","author":"JI Patel","year":"2008","unstructured":"Patel JI, Saleh GM, Hykin PG, Gregor ZJ, Cree IA (2008) Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (Lond) 22:223\u2013228. \n                    https:\/\/doi.org\/10.1038\/sj.eye.6702584","journal-title":"Eye (Lond)"},{"key":"4169_CR40","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/IAE.0b013e31816576d5","volume":"28","author":"P Murugeswari","year":"2008","unstructured":"Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V (2008) Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales\u2019 disease. Retina 28:817\u2013824. \n                    https:\/\/doi.org\/10.1097\/IAE.0b013e31816576d5","journal-title":"Retina"},{"key":"4169_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0021-5155(01)00452-X","volume":"46","author":"E Shimizu","year":"2002","unstructured":"Shimizu E, Funatsu H, Yamashita H, Yamashita T, Hori S (2002) Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema. Jpn J Ophthalmol 46:78\u201383","journal-title":"Jpn J Ophthalmol"},{"key":"4169_CR42","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2147\/OPTH.S141821","volume":"11","author":"S Yoshida","year":"2017","unstructured":"Yoshida S, Kobayashi Y, Nakao S et al (2017) Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy. Clin Ophthalmol 11:1697\u20131705. \n                    https:\/\/doi.org\/10.2147\/OPTH.S141821","journal-title":"Clin Ophthalmol"},{"key":"4169_CR43","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00125-004-1628-8","volume":"48","author":"MT Schram","year":"2005","unstructured":"Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD, Prospective Complications Study Group (2005) Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB prospective complications study. Diabetologia 48:370\u2013378. \n                    https:\/\/doi.org\/10.1007\/s00125-004-1628-8","journal-title":"Diabetologia"},{"key":"4169_CR44","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ajpath.2013.05.017","volume":"183","author":"M Sugimoto","year":"2013","unstructured":"Sugimoto M, Cutler A, Shen B et al (2013) Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage. Am J Pathol 183:987\u2013195. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2013.05.017","journal-title":"Am J Pathol"},{"key":"4169_CR45","first-page":"219","volume":"18","author":"H Chen","year":"2012","unstructured":"Chen H, Wen F, Zhang X, Su SB (2012) Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy. Mol Vis 18:219\u2013226","journal-title":"Mol Vis"},{"key":"4169_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cca.2005.11.029","volume":"367","author":"S Jacqueminet","year":"2006","unstructured":"Jacqueminet S, Ben Abdesselam O, Chapman MJ, Nicolay N, Foglietti MJ, Grimaldi A, Beaudeux JL (2006) Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy. Clin Chim Acta 367:103\u2013107. \n                    https:\/\/doi.org\/10.1016\/j.cca.2005.11.029","journal-title":"Clin Chim Acta"},{"key":"4169_CR47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10384-017-0525-x","volume":"61","author":"K Kimura","year":"2017","unstructured":"Kimura K, Orita T, Kobayashi Y, Matsuyama S, Fujimoto K, Yamauchi K (2017) Concentration of acute phase factors in vitreous fluid in diabetic macular edema. Jpn J Ophthalmol 61:479\u2013483. \n                    https:\/\/doi.org\/10.1007\/s10384-017-0525-x","journal-title":"Jpn J Ophthalmol"},{"key":"4169_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000475603","volume":"238","author":"H Noma","year":"2017","unstructured":"Noma H, Mimura T, Yasuda K, Motohashi R, Kotake O, Shimura M (2017) Aqueous humor levels of soluble vascular endothelial growth factor receptor and inflammatory factors in diabetic macular edema. Ophthalmologica 238:81\u201388. \n                    https:\/\/doi.org\/10.1159\/000475603","journal-title":"Ophthalmologica"},{"key":"4169_CR49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4274\/jcrpe.3082","volume":"8","author":"MA Talat","year":"2016","unstructured":"Talat MA, Sherief LM, El-Saadany HF, Rass AA, Saleh RM, Sakr MM (2016) The role of Osteopontin in the pathogenesis and complications of type 1 diabetes mellitus in children. J Clin Res Pediatr Endocrinol 8:399\u2013404. \n                    https:\/\/doi.org\/10.4274\/jcrpe.3082","journal-title":"J Clin Res Pediatr Endocrinol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-4169-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T17:13:05Z","timestamp":1572455585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-4169-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4169"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-4169-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"24 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the intramural IFO\/Bietti Ethics committee and conducted in accordance with the ethical standards stated in the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}